Qiagen’s $191 Million acquisition of STAT-Dx

Paolo Bossi

Dechert LLP is advising the selling shareholders on the proposed sale of STAT-Dx, a privately owned Spanish molecular diagnostics company, to QIAGEN N.V QIAGEN N.V. (NYSE:…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now